Home › Follicular Lymphoma › Mississippi
Follicular Lymphoma clinical trials in Mississippi
4 studies for Follicular Lymphoma are looking for participants at sites in Mississippi.
Cities in Mississippi
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- University of Mississippi Medical Center, Jackson
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT07215910A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Hattiesburg Clinic, Hattiesburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT06149286A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Hattiesburg Clinic Hematology/Oncology, Hattiesburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06911502SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hattiesburg
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.